Facilitating the identification of cryo-EM hit matter in drug discovery with Astex-Faro
- 1Astex Pharmaceuticals, Cambridge, United Kingdom
Abstract
Cryogenic electron microscopy (cryo-EM) is emerging as a tool for large-scale ligand screening and fragment-based drug discovery, generating extensive collections of reconstructions. At the same time, the systematic inspection of local density variations remains challenging, particularly when identifying weak or partially occupied features. Here, we present Astex-Faro, a statistical framework that defines an expected specimen state from a reference ensemble and identifies significant structural deviations in a target map through comparison against this reference. Furthermore, the method allows the enhancement of weak or poorly resolved features, enabling the recovery of signals that would otherwise be difficult to interpret. Fourier Shell Coherence (FSCoh) is introduced as a metric that quantifies consistency across reconstruction ensembles. We show that Astex-Faro reliably detects subtle structural features and improves their interpretability across datasets spanning a broad range of experimental challenges, from highly homogeneous specimens to membrane proteins, low-occupancy ligands and fragment-screening experiments. Together, these developments provide a practical framework for cryo-EM screening, increasing confidence in hit identification and reducing the risk of missed binding events.
Related
- A learning-to-rank framework for large-scale identification of unknown proteins from cryo-EM and cryo-ET maps
- CryoConvNeXt enables robust identification of low-abundance molecular species in experimental cryo-EM data
- AI-integrated iPSC multi-omics: advancing phenotype discovery and drug target identification in rare diseases
- Proxi MaZiQ array Target Discovery Platform: cell-free identification of drug-interacting proteins using Drug~AirID2C and recombinant human protein arrays
- GPR182 promotes atherosclerosis via facilitating arterial lipid deposition
BibTeX
@misc{isidrogomez2026facilitating,
title = {{Facilitating the identification of cryo-EM hit matter in drug discovery with Astex-Faro}},
author = {F. P. de Isidro-Gomez and C. O. S. Sorzano and J.-M. Carazo and M. Saur},
howpublished = {bioRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.03.763890},
url = {https://www.biorxiv.org/content/10.64898/2026.11.03.763890v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Facilitating the identification of cryo-EM hit matter in drug discovery with Astex-Faro
AU - F. P. de Isidro-Gomez
AU - C. O. S. Sorzano
AU - J.-M. Carazo
AU - M. Saur
PY - 2026
DA - 2026/11/03
PB - bioRxiv
DO - 10.64898/2026.11.03.763890
UR - https://www.biorxiv.org/content/10.64898/2026.11.03.763890v1
AB - Cryogenic electron microscopy (cryo-EM) is emerging as a tool for large-scale ligand screening and fragment-based drug discovery, generating extensive collections of reconstructions. At the same time, the systematic inspection of local density variations remains challenging, particularly when identifying weak or partially occupied features. Here, we present Astex-Faro, a statistical framework that defines an expected specimen state from a reference ensemble and identifies significant structural deviations in a target map through comparison against this reference. Furthermore, the method allows the enhancement of weak or poorly resolved features, enabling the recovery of signals that would otherwise be difficult to interpret. Fourier Shell Coherence (FSCoh) is introduced as a metric that quantifies consistency across reconstruction ensembles. We show that Astex-Faro reliably detects subtle structural features and improves their interpretability across datasets spanning a broad range of experimental challenges, from highly homogeneous specimens to membrane proteins, low-occupancy ligands and fragment-screening experiments. Together, these developments provide a practical framework for cryo-EM screening, increasing confidence in hit identification and reducing the risk of missed binding events.
ER -